Raleigh, NC (PRWEB) October 20, 2010
Trio Clinical Research, a leading clinical research services company supporting the pharmaceutical, biotechnology and medical device industry, announced today that Director Clinical Operations Launi Masterson will speak at MAGI's Clinical Research Conference - 2010 West, October 24-27, in San Francisco, CA.
Ms. Masterson will speak at an interactive workshop on "Productive Sponsor-Site-CRO Relationships" on Sunday, October 24 at 1:00 p.m. Co-presenting alongside her will be Achaogen's Senior Director Clinical Operations Nancy Havrilla and Fresenius Medical Care's Director Clinical Studies Veronica Legg. The session will evaluate the essential requirements for effective relationships between biopharmaceutical sponsors, investigative sites and clinical research organizations: realistic expectations, clear communications, shared understandings, practical policies and efficient problem resolution. The session will also address the common obstacles to attaining effective three-way relationships between biopharmaceutical sponsors, investigative sites and clinical research organizations and how to avoid such obstacles or mitigate them.
The MAGI conference will offer a total of 92 sessions and workshops across six clinical research tracks: site operations, biopharmaceutical sponsor operations, regulatory and ethics, contracts, budgets and billing and special topics.
Ms. Masterson will also moderate the session, "Just CROs: Challenges and Solutions" on Monday, October 25 at 4:45 p.m.
About Trio Clinical Research
Trio Clinical Research is an innovative clinical research services company supporting the pharmaceutical, biotechnology and medical device industries in their quest to bring novel products to the market. Founded in 2002, Trio provides comprehensive clinical trial management, functional outsourcing and clinical research resourcing services across a wide-range of therapeutic areas in phase I-IV clinical research. Trio's extensive customer base includes a majority of the world's top pharmaceutical and biotech companies. For more information, please visit us at http://www.trioclinicalresearch.com.